2.24
price up icon0.45%   0.01
after-market Dopo l'orario di chiusura: 2.26 0.02 +0.89%
loading
Precedente Chiudi:
$2.23
Aprire:
$2.25
Volume 24 ore:
40,865
Relative Volume:
0.02
Capitalizzazione di mercato:
$4.82M
Reddito:
-
Utile/perdita netta:
$-11.28M
Rapporto P/E:
-0.7442
EPS:
-3.01
Flusso di cassa netto:
$-9.78M
1 W Prestazione:
+1.82%
1M Prestazione:
+0.90%
6M Prestazione:
-72.48%
1 anno Prestazione:
-70.12%
Intervallo 1D:
Value
$2.15
$2.30
Intervallo di 1 settimana:
Value
$2.15
$2.30
Portata 52W:
Value
$1.62
$14.67

Ensysce Biosciences Inc Stock (ENSC) Company Profile

Name
Nome
Ensysce Biosciences Inc
Name
Telefono
(858) 263-4196
Name
Indirizzo
7946 IVANHOE AVENUE, LA JOLLA
Name
Dipendente
8
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
ENSC's Discussions on Twitter

Confronta ENSC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ENSC
Ensysce Biosciences Inc
2.24 4.82M 0 -11.28M -9.78M -3.01
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Ensysce Biosciences Inc Borsa (ENSC) Ultime notizie

pulisher
Jun 15, 2025

Short Interest in Ensysce Biosciences, Inc. (NASDAQ:ENSC) Declines By 71.5% - Defense World

Jun 15, 2025
pulisher
Jun 11, 2025

Leading Pain Experts Reveal New Opioid Abuse Prevention Technology at World's Largest Pain Conference - Stock Titan

Jun 11, 2025
pulisher
Jun 11, 2025

(ENSC) On The My Stocks Page - news.stocktradersdaily.com

Jun 11, 2025
pulisher
Jun 07, 2025

Ensysce Biosciences (NASDAQ:ENSC) Trading 1.7% Higher – Here’s What Happened - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

ensysce biosciences appoints baker tilly as new auditor By Investing.com - Investing.com South Africa

Jun 05, 2025
pulisher
Jun 05, 2025

ensysce biosciences appoints baker tilly as new auditor - Investing.com

Jun 05, 2025
pulisher
Jun 04, 2025

Ensysce Flat on Receiving Grant - Baystreet.ca

Jun 04, 2025
pulisher
Jun 04, 2025

Ensysce Biosciences secures additional $5.3M NIDA grant - Investing.com Australia

Jun 04, 2025
pulisher
Jun 04, 2025

Ensysce Biosciences secures additional $5.3M NIDA grant By Investing.com - Investing.com Canada

Jun 04, 2025
pulisher
Jun 04, 2025

Ensysce Biosciences (ENSC) Secures $5.3M Grant to Advance Opioid Development | ENSC Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Revolutionary Opioid With Built-in Overdose Protection Secures $5.3M NIH Grant After FDA Breakthrough Status - Stock Titan

Jun 04, 2025
pulisher
Jun 01, 2025

Ensysce Biosciences (NASDAQ:ENSC) Raised to Hold at Wall Street Zen - Defense World

Jun 01, 2025
pulisher
May 29, 2025

When (ENSC) Moves Investors should Listen - news.stocktradersdaily.com

May 29, 2025
pulisher
May 19, 2025

Where are the Opportunities in (ENSC) - news.stocktradersdaily.com

May 19, 2025
pulisher
May 17, 2025

Zacks Small Cap Analysts Boost Earnings Estimates for ENSC - Defense World

May 17, 2025
pulisher
May 16, 2025

Ensysce Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 16, 2025
pulisher
May 15, 2025

Ensysce Biosciences Advances in Pain Relief Innovation - TipRanks

May 15, 2025
pulisher
May 13, 2025

Revolutionary Opioid Treatment Proves Overdose-Proof in Clinical Trials, Secures Key Patent - Stock Titan

May 13, 2025
pulisher
May 12, 2025

Ensysce Biosciences Bolsters Management Team with Regulatory Expert - Stock Titan

May 12, 2025
pulisher
May 11, 2025

Head-To-Head Contrast: CV Sciences (OTCMKTS:CVSI) and Ensysce Biosciences (NASDAQ:ENSC) - Defense World

May 11, 2025
pulisher
May 08, 2025

(ENSC) Trading Signals - news.stocktradersdaily.com

May 08, 2025
pulisher
May 02, 2025

Ensysce Biosciences (ENSC) to Release Earnings on Friday - Defense World

May 02, 2025
pulisher
Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 25, 2025

Ensysce Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 25, 2025

Ensysce Biosciences, Inc. Announces Closing of $3.0 Million Registered Direct Offering Priced at-the-Market Under NASDAQ Rules - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 25, 2025

Ensysce Biosciences Inc (ENSC) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Sete News

Apr 25, 2025
pulisher
Apr 24, 2025

Ensysce Biosciences Secures $2.2M Funding Boost: Key Details on TAAP/MPAR Program Advancement - Stock Titan

Apr 24, 2025
pulisher
Apr 24, 2025

Ensysce Biosciences Stock Price, Quotes and Forecasts | NASDAQ:ENSC - Benzinga

Apr 24, 2025
pulisher
Apr 24, 2025

Ensysce Biosciences announces exercise of warrants for $2.2M gross proceeds - MSN

Apr 24, 2025
pulisher
Apr 24, 2025

For Array Technologies Inc [ARRY], Analyst sees a rise to $7. What next? - dbtnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Ensysce Biosciences (ENSC) Stock Surges on Patent News - GuruFocus

Apr 24, 2025
pulisher
Apr 24, 2025

Ensysce Biosciences (ENSC) Secures $2.2 Million Through Warrant Exercise - GuruFocus

Apr 24, 2025
pulisher
Apr 23, 2025

Ensysce Biosciences to raise $2.2 million through warrant exercise By Investing.com - Investing.com Canada

Apr 23, 2025
pulisher
Apr 23, 2025

Ensysce Biosciences secures patent for OUD treatment By Investing.com - Investing.com South Africa

Apr 23, 2025
pulisher
Apr 23, 2025

Ensysce Biosciences Stock Doubles In One Trading SessionHere's Why - AOL.com

Apr 23, 2025
pulisher
Apr 23, 2025

Ensysce Biosciences to raise $2.2 million through warrant exercise - Investing.com Australia

Apr 23, 2025
pulisher
Apr 23, 2025

Ensysce Biosciences Inc’s Shares Reel: -58.79% Quarterly Revenue Decline Amid 5.62M Market Cap - investchronicle.com

Apr 23, 2025
pulisher
Apr 23, 2025

Dropbox Inc: Weathering Stock Market Storms with 7.92B Market Cap - investchronicle.com

Apr 23, 2025
pulisher
Apr 23, 2025

Nuvation Bio Inc Inc. (NUVB) Price Performance: A Technical Analysis Perspective - investchronicle.com

Apr 23, 2025
pulisher
Apr 23, 2025

Ensysce Biosciences Raises Fresh $2.2M Capital: H.C. Wainwright Backs Strategic Warrant Deal - Stock Titan

Apr 23, 2025
pulisher
Apr 23, 2025

Sabre Corp (SABR) Stock: From Low to High in 52 Weeks - investchronicle.com

Apr 23, 2025
pulisher
Apr 23, 2025

Analysts Are Recommending Ensysce Biosciences Inc (ENSC) As A Buy Candidate - Marketing Sentinel

Apr 23, 2025
pulisher
Apr 23, 2025

Ensysce Biosciences Inc (NASDAQ:ENSC) stock: You might be surprised - uspostnews.com

Apr 23, 2025
pulisher
Apr 23, 2025

Amentum Holdings Inc (AMTM) Shares Are Down -4.43% YTD - Marketing Sentinel

Apr 23, 2025
pulisher
Apr 23, 2025

Crude Oil Falls Over 3%; Philip Morris Earnings Top Views - Benzinga

Apr 23, 2025
pulisher
Apr 23, 2025

The Psychology of Altria Group Inc Inc. (MO) Price Performance: Understanding Market Sentiment - investchronicle.com

Apr 23, 2025
pulisher
Apr 23, 2025

Ensysce (ENSC) Stock Sees Market Uplift Following New Patent Approval - Stocks Telegraph

Apr 23, 2025
pulisher
Apr 23, 2025

The Psychology of Metsera Inc Inc. (MTSR) Price Performance: Understanding Market Sentiment - investchronicle.com

Apr 23, 2025
pulisher
Apr 23, 2025

(ENSC) Technical Data - news.stocktradersdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

Safety Shot Inc Inc. (SHOT) Price Performance: A Technical Analysis Perspective - investchronicle.com

Apr 23, 2025
pulisher
Apr 23, 2025

Ensysce (ENSC) Advances PF614-MPAR in Overdose Protection Trial - GuruFocus

Apr 23, 2025

Ensysce Biosciences Inc Azioni (ENSC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
Capitalizzazione:     |  Volume (24 ore):